Skip to main content

Table 3 Antihypertensive & hypoglycemic Agents among study participants at JUMC, 2017

From: Blood pressure control and its determinants among diabetes mellitus co-morbid hypertensive patients at Jimma University medical center, South West Ethiopia

Medications Frequency Percentage
1. Antihypertensive agents
Monotherapy 31 23.66
 Enalapril 14 10.68
 Amlodipine 9 6.87
 Nifedipine 4 3.05
 Hydrochlorothiazide 3 2.29
 Atenolol 1 0.76
Dual therapy 89 67.94
 Hydrochlorothiazide + Enalapril 23 17.55
 Hydrochlorothiazide + Atenolol 7 5.34
 Enalapril + Amlodipine 43 32.82
 Atenolol + Amlodipine 2 1.53
 Enalapril + Atenolol 12 9.16
 Losartan +Amlodipine 2 1.53
Triple Therapy 11 8.40
 Hydrochlorothiazide + Enalapril + Amlodipine 5 3.82
 Furosemide + Enalapril +Amlodipine 2 1.53
 Metoprolol + Enalapril + Furosemide 4 3.05
2. Antidiabetic agents
 Insulin 59 45.04
 Oral hypoglycemic 45 34.35
 Insulin + Oral hypoglycemic 27 20.61